Otsuka Pharmaceutical Co. Ltd.’s indirect US subsidiary Otsuka America Pharmaceutical Inc. has purchased the assets and intellectual property of distressed private US venture Proteus Digital Health, Inc. as the developer of ingestible and wearable sensor technology moves out of bankruptcy at a fire sale price.
The deal, confirmed in a brief statement from the major Japanese firm, throws a lifeline to Redwood City, CA-based Proteus, which just a few years ago was considered a digital health “unicorn” but this
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?